Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26? [Yahoo! Finance]
Cardinal Health, Inc. (CAH)
Last cardinal health, inc. earnings: 2/6 06:55 am
Check Earnings Report
US:NYSE Investor Relations:
ir.cardinalhealth.com/home
Company Research
Source: Yahoo! Finance
Cardinal Health 's CAH accelerating specialty strategy is increasingly becoming the centerpiece of its earnings expansion story in fiscal 2026. Following a strong first half, the company raised its fiscal 2026 adjusted earnings per share guidance to $10.15-$10.35, implying 23-26% year-over-year EPS growth and reflecting both strong operational execution and continued demand across its pharmaceutical platform. The momentum is largely driven by Cardinal Health's Pharmaceutical and Specialty Solutions segment, which continues to benefit from strong demand for brand and specialty drugs as well as improved operational efficiency. Segmental profit growth in the quarter was supported by a favorable product mix and disciplined cost management, allowing operating earnings to rise significantly even as the company continues investing in its growth initiatives. A key pillar of this strategy is the rapid expansion of Cardinal Health's specialty ecosystem. Management expects specialty revenue
Show less
Read more
Impact Snapshot
Event Time:
CAH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAH alerts
High impacting Cardinal Health, Inc. news events
Weekly update
A roundup of the hottest topics
CAH
News
- CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable? [Yahoo! Finance]Yahoo! Finance
- Is Cardinal Health Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- New FDA guidance could elevate pharma's biosimilar market [Yahoo! Finance]Yahoo! Finance
- Cardinal Health, Inc. (CAH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Cardinal Health (CAH) had its "outperform" rating reaffirmed by Leerink Partners.MarketBeat
CAH
Earnings
- 2/5/26 - Beat
CAH
Sec Filings
- 3/5/26 - Form 8-K
- 3/3/26 - Form 4
- 2/27/26 - Form 144
- CAH's page on the SEC website